With the completion of genomic analysis in lung cancer by The Cancer Genome Atlas (TCGA) Research Network 6, 7, more and more sensitizing molecular alterations have been identified in genes such as KRAS, ROS1, RET, BRAF, HER2, MET exon 14, and PIK3CA that could potentially be targeted in NSCLC 8, 9. Here, KRAS is linked to non-small cell lung carcinoma.